Antimicrobial therapy in the myelo- and immuno-compromised patient.
Neth J Med, 1979;22(4):118-22.
van den Broek PJ, van der Meer JW
PMID: 113688
Impact factor: 1.105
MeSH terms
Agranulocytosis; Anti-Bacterial Agents; Humans; Immunologic Deficiency Syndromes; Infection Control; Infections; Patient Care Planning; Time Factors
More resources
EndNote: Download